Nebivolol 2.5 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Nebivolol 2.5 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Highly selective beta-1 blocker with NO-mediated vasodilation
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Nebivolol 2.5 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Nebivolol 2.5 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Nebivolol 2.5 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Nebivolol 2.5 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Essential hypertension
- Stable heart failure in elderly (SENIORS-supported)
- Hypertension with metabolic syndrome
- Hypertension with erectile dysfunction (less likely to worsen)
Mechanism of Action
Nebivolol's d-isomer provides high beta-1 selectivity, while the l-isomer activates endothelial beta-3 receptors, releasing nitric oxide and producing peripheral vasodilation. The combination gives BP reduction with reduced fatigue, less effect on lipid/glucose profile, and less worsening of exercise tolerance compared to older beta-blockers.
Dosage & Administration
- Hypertension: 5 mg once daily (range 2.5–10 mg)
- Heart failure in elderly: start 1.25 mg, titrate to 10 mg over 6 weeks
- Take with or without food
- Reduce dose in severe renal impairment
Side Effects
- Fatigue (less than other beta-blockers)
- Headache
- Mild bradycardia
- Dizziness
- GI upset
Contraindications
- Severe bradycardia
- Second/third degree AV block
- Cardiogenic shock
- Decompensated heart failure
- Severe asthma
- Severe hepatic impairment
Storage
Store below 25°C.
PCD Pharma Franchise for Nebivolol 2.5 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Nebivolol 2.5 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Nebivolol 2.5 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Nebivolol 2.5 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Nebivolol 2.5 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Nebivolol 2.5 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Nebivolol 2.5 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Nebivolol 2.5 mg Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for Nebivolol 2.5 mg Tablet?
MRPs range from ₹850 to ₹850 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Nebivolol 2.5 mg Tablet?